Insider · CIK 0001290208
Hoffman Michael B
Reports to the SEC for 10 companies · NEW YORK, NY
Transactions
50
Companies
10
Filings
10
CIK
0001290208
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-27 | TDACTranslational Development Acquisition Corp. · WarrantsP Purchase | +$42.3K |
| 2026-05-20 | ANVSAnnovis Bio, Inc.P Purchase | +$104K |
| 2026-05-20 | ANVSAnnovis Bio, Inc.P Purchase | +$33.9K |
| 2026-05-20 | ANVSAnnovis Bio, Inc.P Purchase | +$4,483.5 |
| 2026-04-02 | ANVSAnnovis Bio, Inc.P Purchase | +$1.5M |
| 2025-12-08 | ANVSAnnovis Bio, Inc.P Purchase | +$130K |
| 2025-12-08 | ANVSAnnovis Bio, Inc.P Purchase | +$63.6K |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$1,718.1 |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$35.4K |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$117K |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$6,149.57 |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$117K |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$6,149.57 |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$1,718.1 |
| 2025-11-24 | ANVSAnnovis Bio, Inc.P Purchase | +$35.4K |
| 2025-11-21 | ANVSAnnovis Bio, Inc.P Purchase | +$34.9K |
| 2025-11-21 | ANVSAnnovis Bio, Inc.P Purchase | +$35K |
| 2025-11-14 | ANVSAnnovis Bio, Inc.P Purchase | +$31.6K |
| 2025-10-28 | ANVSAnnovis Bio, Inc.P Purchase | +$2M |
| 2025-08-29 | ANVSAnnovis Bio, Inc.A Award | +$11.5K |
| 2025-08-29 | ANVSAnnovis Bio, Inc.A Award | +$11.5K |
| 2025-08-29 | ANVSAnnovis Bio, Inc.A Award | +$11.4K |
| 2025-08-19 | ANVSAnnovis Bio, Inc.A Award | +$13.7K |
| 2025-08-19 | ANVSAnnovis Bio, Inc.A Award | +$17.5K |
| 2025-08-19 | ANVSAnnovis Bio, Inc.A Award | +$2,827 |
| 2025-08-19 | ANVSAnnovis Bio, Inc.A Award | +$14.3K |
| 2025-06-13 | ANVSAnnovis Bio, Inc.A Award | +$2.83 |
| 2025-06-13 | ANVSAnnovis Bio, Inc.A Award | +$70K |
| 2025-05-29 | ANVSAnnovis Bio, Inc.A Award | +$12.2K |
| 2023-11-20 | ANVSAnnovis Bio, Inc.A Award | +$1M |
| 2023-11-20 | ANVSAnnovis Bio, Inc.A Award | +$1M |
| 2023-11-17 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2023-04-07 | ANVSAnnovis Bio, Inc.A Award | +$750K |
| 2023-01-18 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2022-01-04 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-01-04 | ANVSAnnovis Bio, Inc.F Tax Payment | −$1,780.2 |
| 2022-01-04 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-01-04 | ANVSAnnovis Bio, Inc.M Exercise/Conversion | +$132K |
| 2022-01-04 | ANVSAnnovis Bio, Inc.M Exercise/Conversion | +$1,785.5 |
| 2022-01-04 | ANVSAnnovis Bio, Inc.F Tax Payment | −$132K |
| 2022-01-03 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2021-07-07 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2020-08-27 | TRAWTraws Pharma, Inc.S Sale | −$510.084 |
| 2020-08-27 | TRAWTraws Pharma, Inc.S Sale | −$49.6K |
| 2020-07-09 | TRAWTraws Pharma, Inc. · Stock Appreciation RightA Award | — |
| 2020-07-01 | ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2020-01-31 | ANVSAnnovis Bio, Inc. · Series A Preferred StockC Conversion | — |
| 2020-01-31 | ANVSAnnovis Bio, Inc.P Purchase | +$200K |
| 2020-01-31 | ANVSAnnovis Bio, Inc. · Convertible NoteC Conversion | −$268K |
| 2020-01-31 | ANVSAnnovis Bio, Inc. · Series A-1 Preferred StockC Conversion | — |
Recent filings
- 4Hoffman Michael B0001104659-26-068236SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-26-065311SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-26-039675SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-25-119407SEC(opens sec.gov)
- 4/AHoffman Michael B0001104659-25-116084SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-25-115801SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-25-115090SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-25-113459SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-25-109905SEC(opens sec.gov)
- 4Hoffman Michael B0001104659-25-087077SEC(opens sec.gov)
Companies
- Annovis Bio, Inc.DirectorANVS
- BUCKEYE PARTNERS, L.P.Director
- Embark Technology, Inc.President
- Enviva, LLCDirector
- Northern Genesis Acquisition Corp.President
- Northern Genesis Acquisition Corp. IIIPresident
- Pattern Energy Group Inc.Director
- Talen Energy CorpDirectorTLN
- Translational Development Acquisition Corp.Director, Chairman and CEOTDAC
- Traws Pharma, Inc.DirectorTRAW
Address
C/O TRANSLATIONAL DEVELOPMENT ACQ CORP. 52 E. 83RD STREET
NEW YORK, NY, 10028